SUCCESS RATE

SUCCESS RATE

GENERA Group is a national and international point of reference both for the high quality of treatments offered and for the scientific strictness of the protocols applied, as demonstrated by the large number of scientific publications produced by the Group each year.

The success of an ART treatment is defined as the cumulative percentage of full-term pregnancy (children born) obtained, compared to cycles started. This key indicator takes into account fresh treatments and any treatments performed with cryopreserved embryos from the same cycle.

NB. Our center focuses on the rate of children born because the pregnancy rate (without delivery) is not a sufficient indicator to define results of ART, since it does not take into account the risk of abortion.

Strong efficiency of the treatments offered: from 2010 to today…

10751

COUPLES TREATED

3288

BABIES BORN

13772

EGGS RETRIEVALS (OPU)

12470

EMBRYO TRANSFER (ET)

*Official data reported to the IVF National Register of the Italian Authority (ISS)

FULL TERM PREGNANCIES PER ET

(2017 data) 

30.4%

GENERA GROUP

18.4%

NATIONAL AVERAGE (ISS)

Sharing validated therapeutic procedures and protocols and the expertise of the entire GENERA team has allowed us to achieve significantly higher results than the national average, marked by constant improvement over the years.

The definition of clinical success cannot ignore the protection of women and children’s health.

Clinical strategies adopted by the GENERA group were found to be very efficient both in reducing the risk of abortion in women over the age of 35, and in reducing the incidence of twin pregnancy and thus improving obstetric outcomes compared to the national average.

 

*The chance of getting a birth is expressed as a percentage for Embryo Transfer (ET). These data refer to transfers of fresh and frozen embryos.

Genera centers data 2017

Full pregnancy rate per IVF/ICSI cycle according to the age of the woman

(IVF Cycles, own eggs)

Although the average age of patients of the GENERA centers, who access our clinics for level II or III treatments, is significantly higher than the national average (38.2 vs 36.7), our treatments result in a higher rate of full term pregnancy.

AGE <35 :

Clinical pregnancies0%
51 %
Full term pregnancies0%
42 %

AGE 35-39 :

Clinical pregnancies0%
38 %
Full term pregnancies0%
32 %

AGE 40-42 :

Clinical pregnancies0%
20 %
Full term pregnancies0%
16 %

AGE >43 :

Clinical pregnancies0%
8 %
Full term pregnancies0%
4 %

Sophisticated clinical and laboratory procedures to face the most difficult cases

The implementation of sophisticated clinical procedures (personalized ovarian stimulation) and laboratory procedures (such as embryonic culture up to the blastocyst stage and the preimplantation genetic test, aimed at acquiring information on the vitality and genetic constitution of the embryo) allow to optimize the treatment and to identify the embryo with the highest probability of implantation and with the lowest risk of generating an abortion after the transfer.

Since 2013…

(Mean maternal age: 39 years)

5572

CYCLES STARTED PGT

78%

CYCLES THAT LEAD TO BIOPSY

46%

OF EMBRYOS WITH NORMAL CHROMOSOMAL STRUCTURE 

25.3%

FULL TERM PREGNANCIES PER OPU

42%

FULL TERM PREGNANCIES PER ET

Effective cryopreservation program

Since  2010 to 2018

(homologous gametes)

7577

EMBRYO THAWING CYCLES

98.7%

TRANSFER DONE

36.4%

FULL TERM PREGNANCIES PER ET

Efficient egg donation program: since 2015 to 2018

The number of oocytes made available for the couple is crucial in obtaining a pregnancy, which is why more than 6 vitrified oocytes per thawing cycle are always made available in our centers.

273

OOCYTE THAWING CYCLES

57.3%

CUMULATIVE FULL TERM PREGNANCIES FOR A CLOSED CYCLE

79.3%

CYCLES WITH CYO-PRESERVED BLASTOCYSTS

Reduction of the risk of miscarriage in patients over 35 years of age

(IVF cycles 2017, own eggs)

20.9%

GENERA GROUP

38.6%

NATIONAL AVERAGE (ISS)

Reduction of the incidence of twin pregnancies

Our policy of transferring a single blastocyst in women under the age of 35 or a single euploid blastocyst in cases of pre-implantation diagnosis, has guaranteed a significant reduction in the incidence of twin pregnancy and an unchanged treatment efficacy in all age groups of women.

Twin pregnancies

(2017 data)

2.6%

GENERA GROUP

15%

NATIONAL AVERAGE (ISS)

Obstetric outcomes improvements

Single embryo transfer policies has also made it possible to improve obstetric outcomes with a reduction in pre-term babies and those born under weight compared to the national average.

2017

PRE-TERM BIRTHS

11.2%

GENERA GROUP

17.3%

NATIONAL AVERAGE (ISS)

2017

BORN UNDER WEIGHT

7.2%

GENERA GROUP

18.5%

NATIONAL AVERAGE (ISS)